Pharmabiz23m
Dizal gets China NMPA breakthrough therapy designation for sunvozertinib to treat NSCLC with EGFR exon 20 insertion mutations
Dizal gets China NMPA breakthrough therapy designation for sunvozertinib to treat NSCLC with EGFR exon 20 insertion mutations: Shanghai, China Tuesday, October 15, 2024, 14:30 Hrs ...
Pharmabiz53m
Exelixis, Merck enter clinical development collaboration to evaluate zanzalintinib in combo with Keytruda in HNSCC and in combo with Welireg in RCC
Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...
Pharmabiz1h
Lupin introduces generic Pred Forte in United States
Global pharma major Lupin Limited (Lupin) announced the launch of the first generic version of Pred Forte (prednisolone acetate) ophthalmic suspension USP, 1% in the United States. Being the first ...
Pharmabiz2h
Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate ...
Pharmabiz2h
USV introduces OnArni for management of heart failure
Our Bureau, Mumbai Tuesday, October 15, 2024, 12:45 Hrs [IST] USV Pvt. Ltd. has introduced OnArni, a fixed dose combination ...
Pharmabiz1h
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...
Pharmabiz3h
Waters new bioseparations tools improve development of RNA-based vaccines and therapies using LC-MS analysis
Waters new bioseparations tools improve development of RNA-based vaccines and therapies using LC-MS analysis: Our Bureau, ...
Pharmabiz22h
Molbio Diagnostics reinforces Goa’s healthcare system with new CSR initiatives
Molbio Diagnostics reinforces Goa’s healthcare system with new CSR initiatives: Our Bureau, Mumbai Monday, October 14, 2024, ...
Pharmabiz4h
GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps
GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps: London, UK Tuesday, October 15, 2024, 10:00 Hrs [IST] GSK ...
Pharmabiz6h
Kerala branch of IPGA to host national annual conference of IPGA in Kochi on December 7
Kerala branch of IPGA to host national annual conference of IPGA in Kochi on December 7: Peethaambaran Kunnathoor, Chennai Tuesday, October 15, 2024, 08:00 Hrs [IST] In academic p ...
Pharmabiz6h
Hospitals designing with AI and data-driven insights aid patients and operational efficiency
Hospitals designing with AI and data-driven insights aid patients and operational efficiency: Nandita Vijayasimha, Bengaluru Tuesday, October 15, 2024, 08:00 Hrs [IST] Integrating ...
Pharmabiz6h
CDSCO should take initiatives to further increase production of APIs in India: M Rajendran
CDSCO should take initiatives to further increase production of APIs in India: M Rajendran: Peethaambaran Kunnathoor, Chennai Tuesday, October 15, 2024, 08:00 Hrs [IST] Hailing th ...